Nanoporous membrane-encapsulated feeder cells for culture of human embryonic stem cells

International Journal of Functional Informatics and Personalised Medicine

Volumn 2, Issue 1, 2009, Pages 77-88

  Zhou, Jing ^a   Xu, Ren He ^b   Wang, Yong ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

hESCs; human embryonic stem cells; MEF; mouse embryonic fibroblasts; nanoporous membrane; pathogen; self renewal

Indexed keywords

EID: 79953277201     PISSN: 17562104     EISSN: 17562112     Source Type: Journal    
DOI: 10.1504/IJFIPM.2009.022838     Document Type: Article

References (35)

1. Abetz, V., Brinkmann, T., Dijkstra, M., Ebert, K., Fritsch, D., Ohlrogge, K., Paul, D., Peinemann, K.V., Nunes, S.P., Scharnagl, N. and Schossig, M. (2006) ‘Developments in membrane research: from material via process design to industrial application’, Advanced Engineering Materials, Vol. 8, No. 5, pp.328–358.
2. Aguzzi, A. and Heikenwalder, M. (2006) ‘Pathogenesis of prion diseases: current status and future outlook’, Nat. Rev. Microbiol., Vol. 4, No. 10, pp.765–775.
3. Bikfalvi, A., Klein, S., Pintucci, G. and Rifkin, D.B. (1997) ‘Biological roles of fibroblast growth factor-2’, Endocr. Rev., Vol. 18, No. 1, pp.26–45.
4. Black, J.G. (1996) Microbiology Principles and Applications, Upper Saddle River, Prentice-Hall, New Jersey.
5. Burnouf, T., Radosevich, M., Goubran, H.A. and Willkommen, H. (2005) ‘Place of nanofiltration for assuring viral safety of biologicals’, Current Nanoscience, Vol. 1, No. 3, pp.189–201.
6. Chai, C. and Leong, K.W. (2007) ‘Biomaterials approach to expand and direct differentiation of stem cells’, Mol. Ther., Vol. 15, No. 3, pp.467–480.
7. Daopin, S., Piez, K.A., Ogawa, Y. and Davies, D.R. (1992) ‘Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily’, Science, Vol. 257, No. 5068, pp.369–373.
8. Desai, T.A., West, T., Cohen, M., Boiarski, T. and Rampersaud, A. (2004) ‘Nanoporous microsystems for islet cell replacement’, Adv. Drug Deliv. Rev., Vol. 56, No. 11, pp.1661–1673.
9. Dowd, C.J., Cooney, C.L. and Nugent, M.A. (1999) ‘Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding’, J. Biol. Chem., Vol. 274, No. 8, pp.5236–5244.
10. Gish, R.G. and Ascher, N.L. (1996) ‘Transmission of hepatitis B virus through allotransplantation’, Liver Transpl. Surg., Vol. 2, No. 2, pp.161–164.
11. Gunzburg, W.H. and Salmons, B. (2000) ‘Xenotransplantation: is the risk of viral infection as great as we thought?’, Mol. Med. Today, Vol. 6, No. 5, pp.199–208.
12. Hoffman, L.M. and Carpenter, M.K. (2005) ‘Characterization and culture of human embryonic stem cells’, Nat. Biotechnol., Vol. 23, No. 6, pp.699–708.
13. Klimanskaya, I., Chung, Y., Meisner, L., Johnson, J., West, M.D. and Lanza, R. (2005) ‘Human embryonic stem cells derived without feeder cells’, Lancet, Vol. 365, No. 9471, pp.1636–1641.
14. Lu, J., Hou, R., Booth, C.J., Yang, S.H. and Snyder, M. (2006) ‘Defined culture conditions of human embryonic stem cells’, Proc. Natl. Acad. Sci. USA, Vol. 103, No. 15, pp.5688–5693.
15. Ludwig, T.E., Levenstein, M.E., Jones, J.M., Berggren, W.T., Mitchen, E.R., Frane, J.L., Crandall, L.J., Daigh, C.A., Conard, K.R., Piekarczyk, M.S., Llanas, R.A. and Thomson, J.A. (2006) ‘Derivation of human embryonic stem cells in defined conditions’, Nat. Biotechnol., Vol. 24, No. 2, pp.185–187.
16. Ma, X., Vacek, I. and Sun, A. (1994) ‘Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions’, Artif Cells Blood Substit. Immobil. Biotechnol., Vol. 22, No. 1, pp.43–69.
17. Manuelidis, L., Yu, Z.X., Banquero, N. and Mullins, B. (2007) ‘Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles’, Proc. Natl. Acad. Sci. USA, Vol. 104, No. 6, pp.1965–1970.
18. Massague, J. (1990) ‘The transforming growth factor-beta family’, Annu. Rev. Cell Biol., Vol. 6, pp.597–641.
19. Murphy, F.A. (1996) ‘The public health risk of animal organ and tissue transplantation into humans’, Science, Vol. 273, No. 5276, pp.746–747.
20. Oh, S.K.W. and Choo, A.B.H. (2006) ‘Human embryonic stem cell technology: large scale cell amplification and differentiation’, Cytotechnology, Vol. 50, Nos. 1-3, pp.181–190.
21. Orsi, N.M. and Reischl, J.B. (2007) ‘Mammalian embryo co-culture: trials and tribulations of a misunderstood method’, Theriogenology, Vol. 67, No. 3, pp.441–458.
22. Rohwedel, J., Guan, K., Hegert, C. and Wobus, A.M. (2001) ‘Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects’, Toxicol In Vitro, Vol. 15, No. 6, pp.741–753.
23. Silveira, J.R., Raymond, G.J., Hughson, A.G., Race, R.E., Sim, V.L., Hayes, S.F. and Caughey, B. (2005) ‘The most infectious prion protein particles’, Nature, Vol. 437, No. 7056, pp.257–261.
24. Sirkar, K.K. (1997) ‘Membrane separation technologies: current developments’, Chemical Engineering Communications, Vol. 157, pp.145–184.
25. Sirkar, K.K. (1997) ‘Membrane separation technologies: current developments’, Chemical Engineering Communications, Vol. 157, pp.145–184.
26. Skottman, H. and Hovatta, O. (2006) ‘Culture conditions for human embryonic stem cells’, Reproduction, Vol. 132, No. 5, pp.691–698.
27. Stojkovic, M., Lako, M., Strachan, T. and Murdoch, A. (2004) ‘Derivation, growth and applications of human embryonic stem cells’, Reproduction, Vol. 128, No. 3, pp.259–267.
28. Thu, B., Bruheim, P., Espevik, T., Smidsrod, O., Soon-Shiong, P. and Skjak-Braek, G. (1996) ‘Alginate polycation microcapsules. II. Some functional properties’, Biomaterials, Vol. 17, No. 11, pp.1069–1079.
29. Wang, X., Wang, W., Ma, J., Guo, X., Yu, X. and Ma, X. (2006) ‘Proliferation and differentiation of mouse embryonic stem cells in APA microcapsule: A model for studying the interaction between stem cells and their niche’, Biotechnol. Prog., Vol. 22, No. 3, pp.791–800.
30. Wang, Y. and Yuan, F. (2006) ‘Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement’, Ann. Biomed. Eng., Vol. 34, No. 1, pp.114–127.
31. Xie, Y., Ma, X., Wang, Y. and Yu, X. (1996) ‘Study of the permeability of biomicrocapsule’, Chinese Journal of Biochemical Pharmaceutics, Vol. 17, No. 5, pp.190–194.
32. Xu, C., Inokuma, M.S., Denham, J., Golds, K., Kundu, P., Gold, J.D. and Carpenter, M.K. (2001) ‘Feeder-free growth of undifferentiated human embryonic stem cells’, Nat. Biotechnol., Vol. 19, No. 10, pp.971–974.
33. Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T. and Thomson, J.A. (2005) ‘Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells’, Nat. Methods, Vol. 2, No. 3, pp.185–190.
34. Yao, S., Chen, S., Clark, J., Hao, E., Beattie, G.M., Hayek, A. and Ding, S. (2006) ‘Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions’, Proc. Natl. Acad. Sci. USA, Vol. 103, No. 18, pp.6907–6912.
35. Zhang, X., Wang, W., Yu, W., Xie, Y., Zhang, X., Zhang, Y. and Ma, X. (2005) ‘Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing’, Biotechnol. Prog., Vol. 21, No. 4, pp.1289–1296.